ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 558 filers reported holding ASTRAZENECA PLC in Q3 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,315,000 | -4.6% | 26,458 | -4.0% | 0.16% | -6.4% |
| Q4 2020 | $1,378,000 | -62.7% | 27,571 | -59.1% | 0.17% | -67.7% |
| Q3 2020 | $3,693,000 | +2.2% | 67,398 | -1.4% | 0.53% | -10.8% |
| Q2 2020 | $3,615,000 | +5.6% | 68,341 | -10.8% | 0.59% | -14.4% |
| Q1 2020 | $3,423,000 | -16.4% | 76,644 | -6.7% | 0.69% | +37.5% |
| Q4 2019 | $4,096,000 | +36.1% | 82,151 | +21.7% | 0.50% | +16.1% |
| Q3 2019 | $3,009,000 | +32.0% | 67,501 | +22.2% | 0.43% | +38.7% |
| Q2 2019 | $2,280,000 | +2.1% | 55,226 | 0.0% | 0.31% | -5.2% |
| Q1 2019 | $2,233,000 | -46.9% | 55,226 | -50.1% | 0.33% | 0.0% |
| Q4 2018 | $4,206,000 | +90.7% | 110,722 | +98.6% | 0.33% | +27.4% |
| Q3 2018 | $2,206,000 | -14.7% | 55,754 | -24.3% | 0.26% | -20.1% |
| Q2 2018 | $2,585,000 | +36.7% | 73,620 | +36.1% | 0.32% | +30.1% |
| Q1 2018 | $1,891,000 | – | 54,078 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |